2025年2月4日 · EPREX should be administered to patients with symptomatic anaemia (e.g. haemoglobin concentration ≤10 g/dL (6.2 mmol/L)). The recommended starting dose is EPREX 450 IU/kg (maximum total dose is 40,000 IU) administered subcutaneously once every week, with not less than 5 days between doses.

Eprex 4000 Injection is a medicine that helps your bone marrow to produce more red blood cells. It is used to treat a type of anemia caused by kidney disease. It is also used to treat anemia caused by cancer chemotherapy and by taking medicines to treat HIV.

2021年1月7日 · 1 package leaflet: information for the user eprex 2,000 iu/ml, 4,000 iu/ml and 10,000 iu/ml solution for injection in pre-filled syringes (epoetin alfa) read all of this leaflet carefully before you start using this medicine because it contains important information for you.

2019年5月22日 · EPREX is prescribed to stimulate your bone marrow to produce more red blood cells. EPREX IS USED TO TREAT ANAEMIA IN ADULTS RECEIVING CHEMOTHERAPY FOR SOLID TUMOURS, malignant lymphoma or multiple myeloma (bone marrow cancer) who may have a need for a blood transfusion.

EPREX 40,000 IU/1.0 mL solution for injection in pre-filled syringe. EPREX ® is a sterile, preservative-free buffered protein solution of epoetin alfa (rch) in pre-filled syringes.

2025年1月30日 · Eprex 4000 IU/ml solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) by Janssen-Cilag Ltd (a Johnson & Johnson Company)

2025年1月24日 · QU’EST-CE QUE EPREX 4000 UI/mL, solution injectable en seringue préremplie ET DANS QUELS CAS EST-IL UTILISE ? Classe pharmacothérapeutique : autres ANTI-ANEMIQUES/ERYTHROPOIETINE - code ATC : B03XA01.

Eprex is used to treat anemia caused by kidney disease, in children on dialysis, in adults on dialysis or peritoneal dialysis, and in adults who have severe anemia but are not yet on peritoneal dialysis. Your doctor has recommended Eprex to stimulate your bone marrow to …

EPREX is used to treat anaemia in adults with a bone marrow disorder that causes a severe disruption in the creation of blood cells (myelodysplastic syndromes).EPREX can reduce the need for a blood transfusion.

EPREX® (epoetin alfa) is indicated to elevate or maintain the red blood cell level (as manifested by the hematocrit or hemoglobin determinations) and to decrease the need for transfusions. Eprex therapy is not intended for patients who require immediate correction of severe anemia.